Načítá se...
5PSQ-011 Evaluation of adherence to new oral anticoagulants therapy based on therapeutic switches: a descriptive study
BACKGROUND: Regarding therapeutic adherence to new oral anticoagulants (NOAC), several studies(1) have shown lower adherence in dabigatran-treated patients compared to rivaroxaban and apixaban. The NOAC introduction has fueled the phenomenon of switching from vitamin K antagonists (VKA) to NOAC, and...
Uloženo v:
| Vydáno v: | Eur J Hosp Pharm |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Group
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535786/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.365 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|